Alejandro Villalba

970 total citations
27 papers, 635 citations indexed

About

Alejandro Villalba is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alejandro Villalba has authored 27 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 11 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alejandro Villalba's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Alejandro Villalba is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Alejandro Villalba collaborates with scholars based in Spain, Netherlands and Germany. Alejandro Villalba's co-authors include Diana Peiteado, Laura Nuño, E. Martín‐Mola, Alejandro Balsa, Chamaida Plasencia, María‐Eugenia Miranda‐Carús, Eugenio de Miguel, Amaya Puig‐Kröger, Dora Pascual‐Salcedo and I. Monjo and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Alejandro Villalba

27 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandro Villalba Spain	15	387	325	114	70	65	27	635
Julie M. Robertson United States	13	399 1.0×	361 1.1×	117 1.0×	37 0.5×	27 0.4×	19	650
Óscar Osío Uribe Colombia	10	426 1.1×	282 0.9×	101 0.9×	75 1.1×	86 1.3×	22	556
Luis Alonso González Colombia	16	412 1.1×	248 0.8×	85 0.7×	26 0.4×	42 0.6×	49	547
F. Houssiau Belgium	9	380 1.0×	173 0.5×	112 1.0×	38 0.5×	37 0.6×	11	472
Athiveeraramapandian Prabu United Kingdom	7	372 1.0×	206 0.6×	119 1.0×	74 1.1×	33 0.5×	14	470
Jose Gabriel Erdozain Spain	8	546 1.4×	186 0.6×	68 0.6×	31 0.4×	135 2.1×	12	611
Irama Villar Spain	8	502 1.3×	177 0.5×	55 0.5×	121 1.7×	95 1.5×	14	634
Lena Björnådal Sweden	8	435 1.1×	217 0.7×	77 0.7×	66 0.9×	38 0.6×	8	601
M. Pha France	10	341 0.9×	166 0.5×	93 0.8×	55 0.8×	24 0.4×	29	481
Arthur F. Kavanaugh United States	13	371 1.0×	377 1.2×	106 0.9×	40 0.6×	156 2.4×	20	689

Countries citing papers authored by Alejandro Villalba

Since Specialization

Citations

This map shows the geographic impact of Alejandro Villalba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Villalba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Villalba more than expected).

Fields of papers citing papers by Alejandro Villalba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Villalba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Villalba. The network helps show where Alejandro Villalba may publish in the future.

Co-authorship network of co-authors of Alejandro Villalba

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Villalba. A scholar is included among the top collaborators of Alejandro Villalba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Villalba. Alejandro Villalba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martínez‐Feito, Ana, Marta Novella-Navarro, Borja Hernández‐Breijo, et al.. (2024). Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases. Lara D. Veeken. 64(1). 344–351. 4 indexed citations

Novella-Navarro, Marta, Alejandro Villalba, Elisa Fernández-Fernández, et al.. (2023). Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment. RMD Open. 9(3). e003382–e003382. 7 indexed citations

Benavent, Diego, Chamaida Plasencia‐Rodríguez, Marta Novella-Navarro, et al.. (2022). Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain. BMJ Open. 12(4). e057850–e057850. 10 indexed citations

Cordero, Oscar J., Irene Viéitez, Laura Nuño, et al.. (2022). Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients. Archivum Immunologiae et Therapiae Experimentalis. 70(1). 12–12. 1 indexed citations

Nuño, Laura, Alejandro Villalba, Rosario García‐Vicuña, et al.. (2021). The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis. Frontiers in Immunology. 12. 776879–776879. 14 indexed citations

Nuño, Laura, Ana M. Ortiz, Alejandro Villalba, et al.. (2021). Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies. Scientific Reports. 11(1). 9945–9945. 4 indexed citations

Bang, Holger, Laura Nuño, Diana Peiteado, et al.. (2020). Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies. Scientific Reports. 10(1). 19263–19263. 10 indexed citations

Villalba, Alejandro, Laura Nuño, Diana Peiteado, et al.. (2020). Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis. Lara D. Veeken. 59(10). 3081–3091. 16 indexed citations

Novella-Navarro, Marta, Chamaida Plasencia, Victoria Navarro‐Compán, et al.. (2020). Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 284–284. 31 indexed citations

10.

Nuño, Laura, Ana M. Ortiz, Alejandro Villalba, et al.. (2019). Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics. Arthritis Research & Therapy. 21(1). 280–280. 14 indexed citations

11.

Nuño, Laura, Alejandro Villalba, Diana Peiteado, et al.. (2019). Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis. Lara D. Veeken. 58(9). 1662–1673. 65 indexed citations

12.

Jurado‐Guerrero, Teresa, Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, et al.. (2017). Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients. The Open Rheumatology Journal. 11(1). 75–87. 13 indexed citations

13.

Nuño, Laura, Ana M. Ortiz, Diana Peiteado, et al.. (2017). Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients. Scientific Reports. 7(1). 12023–12023. 18 indexed citations

14.

Miguel, Eugenio de, Diana Peiteado, Chamaida Plasencia‐Rodríguez, et al.. (2017). Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents. PLoS ONE. 12(7). e0180726–e0180726. 12 indexed citations

15.

Plasencia, Chamaida, E. Kneepkens, Gertjan Wolbink, et al.. (2015). Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity. The Journal of Rheumatology. 42(9). 1638–1646. 29 indexed citations

16.

Peiteado, Diana, Alejandro Villalba, E. Martín‐Mola, & Eugenio de Miguel. (2015). Reduction but not disappearance of Doppler signal after two years of treatment for gout. Do we need a more intensive treatment?. PubMed. 33(3). 385–90. 19 indexed citations

17.

Plasencia, Chamaida, Teresa Jurado‐Guerrero, Alejandro Villalba, et al.. (2015). Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions. Frontiers in Medicine. 2. 71–71. 8 indexed citations

18.

Castillo-Gallego, C., Eugenio de Miguel, Diana Peiteado, et al.. (2014). Decreased Frequencies of Circulating Follicular Helper T Cell Counterparts and Plasmablasts in Ankylosing Spondylitis Patients Naïve for TNF Blockers. PLoS ONE. 9(9). e107086–e107086. 30 indexed citations

19.

Plasencia, Chamaida, Dora Pascual‐Salcedo, Laura Nuño, et al.. (2012). Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab. Annals of the Rheumatic Diseases. 71(12). 1955–1960. 92 indexed citations

20.

Molina, Raquel, Jaime Feliú, Alejandro Villalba, et al.. (2008). Employment in a cohort of cancer patients in Spain. A predictive model of working outcomes. Clinical & Translational Oncology. 10(12). 826–830. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact